OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Showing 7 citing articles:
S‐ketamine Alleviates Neuroinflammation and Attenuates Lipopolysaccharide‐Induced Depression Via Targeting SIRT2
Cong Lin, Xiaoxuan Zhou, Mingqi Li, et al.
Advanced Science (2025)
Open Access
Cong Lin, Xiaoxuan Zhou, Mingqi Li, et al.
Advanced Science (2025)
Open Access
Exosome‐Functionalized Self‐Carrier Enzyme‐Like/Drug With Triple Amplified Anti‐Oxidative Stress for Synergistic Depression Therapy
Hanqing Wang, Yunzhu Xu, Zicheng Zhang, et al.
Small (2025)
Closed Access
Hanqing Wang, Yunzhu Xu, Zicheng Zhang, et al.
Small (2025)
Closed Access
Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential
Qianting Deng, Emily D. Parker, Chongyun Wu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Qianting Deng, Emily D. Parker, Chongyun Wu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Psychoactive substances for the treatment of neuropsychiatric disorders
Zifan Zhen, Xueqiang Sun, Shiying Yuan, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104193-104193
Closed Access | Times Cited: 3
Zifan Zhen, Xueqiang Sun, Shiying Yuan, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104193-104193
Closed Access | Times Cited: 3
Potassium channels in depression: emerging roles and potential targets
Jiahao Zhang, Zhu Yao, Meng Zhang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Jiahao Zhang, Zhu Yao, Meng Zhang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality
Georgios D. Kotzalidis, Federica Fiaschè, Alessandro Alcibiade, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 435-446
Closed Access
Georgios D. Kotzalidis, Federica Fiaschè, Alessandro Alcibiade, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 435-446
Closed Access
Intranasal LAG3 antibody infusion induces a rapid antidepressant effect via the hippocampal ERK1/2-BDNF signaling pathway in chronically stressed mice
Yunli Fang, Hainan Pan, Hao‐Jie Zhu, et al.
Neuropharmacology (2024) Vol. 259, pp. 110118-110118
Closed Access
Yunli Fang, Hainan Pan, Hao‐Jie Zhu, et al.
Neuropharmacology (2024) Vol. 259, pp. 110118-110118
Closed Access
Esketamine Provides Neuroprotection After Intracerebral Hemorrhage in Mice via the NTF3 /PI3K /AKT Pathway
Xiaoyu Niu, Yuanyuan Zheng, Wang Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access
Xiaoyu Niu, Yuanyuan Zheng, Wang Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access
